The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bone metabolism biomarkers in men with advanced prostate cancer (PC) and bone metastases treated with denosumab versus zoledronic acid (ZA).
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen
 
Janet Elizabeth Brown
Consulting or Advisory Role - Amgen; Novartis
Research Funding - Novartis
 
Karim Fizazi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Curevac; Dendreon; Ipsen; Janssen Oncology; Novartis; Orion; Sanofi; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Janssen Oncology; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Laurence Klotz
No Relationships to Disclose
 
Gavin M. Marx
Honoraria - Amgen; Roche; Sanofi
Consulting or Advisory Role - Amgen; Janssen; Roche; Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Huei Wang
Stock and Other Ownership Interests - Amgen
Travel, Accommodations, Expenses - Amgen
 
Douglas Warner
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Allan Lipton
Honoraria - Amgen; Novartis
Consulting or Advisory Role - Amgen; Novartis
Speakers' Bureau - Amgen; Novartis
Research Funding - Amgen; Novartis
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Amgen; Novartis